SA PRO
Free Account
Repligen CorporationRGENNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 87% recommend buying.

Consensus Rating
Buy
23 analysts·High coverage
87%
Rating Distribution
Strong Buy
14%
Buy
1983%
Hold
313%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 20% higher.

Bear Case
$150.00
-1%
Consensus
$181.43
+20%
Bull Case
$205.00
+36%
Price Range23 analysts
Low
Consensus
High
$150.00
$205.00
Current Target
Current Price
$150.88
Upside to Target
$30.56

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 16, 2026UBS
Repligen price target raised to $200 from $190 at UBS
Target:$200.00
+23.7%from $161.69
Dec 15, 2025Wells Fargo
Repligen price target raised to $190 from $175 at Wells Fargo
Target:$190.00
+20.8%from $157.33
Dec 15, 2025Barclays
Repligen price target raised to $200 from $175 at Barclays
Target:$200.00
+27.1%from $157.33
Oct 29, 2025Canaccord Genuity
Repligen price target raised to $165 from $150 at Canaccord
Target:$165.00
+8.9%from $151.57
Oct 29, 2025Barclays
Repligen price target raised to $175 from $160 at Barclays
Target:$175.00
+15.5%from $151.57
Oct 28, 2025Jefferies
Repligen (RGEN) PT Raised to $160 at Jefferies
Target:$160.00
+3.7%from $154.24
Oct 2, 2025Barclays
Repligen price target raised to $160 from $150 at Barclays
Target:$160.00
+9.7%from $145.81
Oct 1, 2025HSBC
Repligen initiated with a Buy at HSBC
Target:$150.00
+12.2%from $133.67
Sep 2, 2025RBC Capital
Repligen price target raised to $205 from $204 at RBC Capital
Target:$205.00
+69.9%from $120.69
Nov 12, 2024KeyBanc
KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Target:$220.00
+48.1%from $148.59
Jul 31, 2024UBS
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Target:$185.00
+10.5%from $167.35
Jul 31, 2024J.P. Morgan
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Target:$200.00
+19.5%from $167.35
Jun 26, 2024Deutsche Bank
Deutsche Bank Upgrades Repligen (RGEN) to Buy
Target:$155.00
+22.0%from $127.00
Jun 21, 2024Stifel Nicolaus
Stifel Out Positive on Repligen (RGEN): 'current levels seem as though they will have proven to be good ones'
Target:$207.00
+68.1%from $123.16
Jan 6, 2023Leerink Partners
SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $200
Target:$200.00
+30.4%from $153.32
Dec 14, 2022Deutsche Bank
Deutsche Bank Initiates Coverage On Repligen with Hold Rating, Announces Price Target of $180
Target:$180.00
+1.1%from $177.99
Dec 7, 2022RBC Capital
RBC Capital Initiates Coverage On Repligen with Sector Perform Rating, Announces Price Target of $190
Target:$190.00
+12.3%from $169.13
Apr 28, 2022Leerink Partners
SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $220
Target:$220.00
+39.7%from $157.51

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance